Eli Lilly (LLY) heads into 2026 with GLP-1 pricing and competition risks; oral GLP-1 race heats up and downside looms.

Biogen Inc.’s new at-home Alzheimer’s drug will give the company an edge over rival Eli Lilly Co.’s competing therapy, its ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.

Adimab's latest partner program to receive approval is GSK's Exdensur (depemokimab), approved in the US for the treatment of severe asthma with an eosinophilic phenotype and in the UK and Japan for ...

The Fischer Theatre will host a special film event uniting firefighters from across the nation, spotlighting a Wichita Fire ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice.

Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area ...

France's Finance ​Ministry said on Monday it had received no formal request for investment approval ‌regarding French biotech ...

In addition, Adimab achieved 50 technical and development milestones across numerous collaborations. Since 2009, Adimab has partnered with over 140 companies to discover therapeutic drug candidates.

Humana’s CenterWell pharmacy will dispense GLP-1 weight loss drugs made by Eli Lilly as part of a new program for employers ...

Indiana has a nearly $1 billion plan to ship water to the LEAP District. Utilities say they won't pass cost to consumers.